These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15930368)

  • 1. New trick for an old enzyme.
    Leslie M
    Sci Aging Knowledge Environ; 2005 Jun; 2005(22):nf41. PubMed ID: 15930368
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomeres: hallmarks of radiosensitivity.
    Ayouaz A; Raynaud C; Heride C; Revaud D; Sabatier L
    Biochimie; 2008 Jan; 90(1):60-72. PubMed ID: 18006207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
    Xiao CY; Zhou FX; Liu SQ; Xie CH; Dai J; Zhou YF
    Ai Zheng; 2005 Jun; 24(6):653-6. PubMed ID: 15946472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity.
    Kurvinen K; Rantanen V; Syrjänen S; Johansson B
    Int J Radiat Biol; 2006 Dec; 82(12):859-67. PubMed ID: 17178626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy.
    Ji XM; Xie CH; Fang MH; Zhou FX; Zhang WJ; Zhang MS; Zhou YF
    Acta Pharmacol Sin; 2006 Sep; 27(9):1185-91. PubMed ID: 16923339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomeres rather than telomerase a key target for anti-cancer therapy?
    Boukamp P; Mirancea N
    Exp Dermatol; 2007 Jan; 16(1):71-9. PubMed ID: 17181645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of telomerase in hematopoietic stem cells.
    Lansdorp PM
    Ann N Y Acad Sci; 2005 Jun; 1044():220-7. PubMed ID: 15958715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere identity crisis.
    Baumgartner BL; Lundblad V
    Genes Dev; 2005 Nov; 19(21):2522-5. PubMed ID: 16264188
    [No Abstract]   [Full Text] [Related]  

  • 12. Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells.
    McCaul JA; Gordon KE; Minty F; Fleming J; Parkinson EK
    Oral Oncol; 2008 Mar; 44(3):261-9. PubMed ID: 17475542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomeres, telomerase and cancer.
    Greider CW; Blackburn EH
    Sci Am; 1996 Feb; 274(2):92-7. PubMed ID: 8560215
    [No Abstract]   [Full Text] [Related]  

  • 14. Telomerase- and capping-independent yeast survivors with alternate telomere states.
    Larrivée M; Wellinger RJ
    Nat Cell Biol; 2006 Jul; 8(7):741-7. PubMed ID: 16767083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeres and telomerase: Biological and clinical importance in dogs.
    Nasir L
    Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The many faces of telomerase: emerging extratelomeric effects.
    Bollmann FM
    Bioessays; 2008 Aug; 30(8):728-32. PubMed ID: 18623070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
    Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
    Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase as a clinical target: current strategies and potential applications.
    Fleisig HB; Wong JM
    Exp Gerontol; 2007; 42(1-2):102-12. PubMed ID: 16814507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do telomeres ask checkpoint proteins: "gimme shelter-in"?
    Weinert T
    Dev Cell; 2005 Dec; 9(6):725-6. PubMed ID: 16326384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.